Related Experiment Video

Updated: Jun 3, 2026

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 6-HYDROXYDOPAMINE ADMINISTRATION INTO BRAIN

George R Breese1, Barrett R Cooper, Ronald D Smith

  • 1Departments of Pharmacology and Psychiatry, Biological Sciences Research Center, Child Development Institute, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514, U.S.A.

Biochemical Pharmacology
|September 28, 2011
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
10:09

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

Related Experiment Videos

Last Updated: Jun 3, 2026

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
10:09

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

Articles linked to this work by shared authors, journal, and citation graph.

Advancements in Assays for Micro- and Nanoplastic Detection: Paving the Way for Biomonitoring and Exposomics Studies.

Annual review of pharmacology and toxicology·2024

Population genetics of transposable element load: A mechanistic account of observed overdispersion.

PloS one·2022

Endosperm-based incompatibilities in hybrid monkeyflowers.

The Plant cell·2021

Phenotyping CCL2 Containing Central Amygdala Neurons Controlling Alcohol Withdrawal-Induced Anxiety.

Frontiers in cellular neuroscience·2020

Amygdala Arginine Vasopressin Modulates Chronic Ethanol Withdrawal Anxiety-Like Behavior in the Social Interaction Task.

Alcoholism, clinical and experimental research·2019

A likelihood ratio test for changes in homeolog expression bias.

BMC bioinformatics·2019

Targeting BRAF dimerization in cancer: structural insights and therapeutic strategies beyond monomer inhibition.

Biochemical pharmacology·2026

Lipoprotein components of probiotics act as negative regulators of bone metabolism via the dual modulation of osteoclast and osteoblast differentiation.

Biochemical pharmacology·2026

Dapagliflozin attenuates cellular senescence and mitochondrial dysfunction in diabetic kidney disease: potential involvement of AMPK/Sirt3 signaling.

Biochemical pharmacology·2026

The role of individual residues in arrestin-3 finger loop in its binding to β2-adrenergic receptor.

Biochemical pharmacology·2026

eIF4A1 enhances p70S6K mRNA translation and promotes nuclear β-catenin levels to augment stemness and metastasis in gastric cancer cells.

Biochemical pharmacology·2026

UCHL1 attenuates diabetic retinopathy by deubiquitinating and stabilizing NRF2 to suppress oxidative stress-induced retinal vascular endothelial ferroptosis.

Biochemical pharmacology·2026

Efficacy and safety evaluation of adalimumab for psoriatic arthritis: A meta-analysis.

Medicine·2026

Safety of ozanimod and etrasimod in ulcerative colitis: A disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System database.

Medicine·2026

Antitumor activity of scorpion venom-derived peptides: A meta-analysis of preclinical studies.

Pharmacological research·2026

Symptom prevalence and pharmacological management of late-stage Parkinson's disease (LSPD): a cross-sectional, multinational survey.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Opioids to Treat Chronic Pain in the Older Adult: A Clinical Consensus to Guarantee Safety and Avoid Adverse Events.

Drugs & aging·2026

Successful rescue of a patient with extensive lethal-dose aluminum phosphide poisoning complicated by multiple organ dysfunction syndrome.

The Journal of international medical research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us